Eramet:企業の戦略・SWOT・財務情報

◆英語タイトル:Eramet - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6674
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:金属・鉱業
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Eramet – Strategy, SWOT and Corporate Finance Report
Summary

Eramet – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Eramet is a mining and metallurgy company. It principally specializes in the production of nickel, manganese and alloys. The company is involved in the production of non-ferrous metals, chemical derivatives, alloys and high-performance parts for industries. It produces super-alloys and specialty steels that resist high heat and corrosion. Its steel products include die-forged and machined parts for the aerospace, power generation and tooling industries. The company also offers manganese products for the production of batteries, fertilizers and animal feed, and steel industry. The company has its presence in 19 countries across Europe, Americas, Africa and Asia. Eramet is headquartered in Paris, France.

Scope

- Detailed information on Eramet required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Eramet in the form of a SWOT analysis
- An in-depth view of the business model of Eramet including a breakdown and examination of key business segments
- Intelligence on Eramet’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Eramet, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Eramet and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Eramet as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Eramet’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Eramet: Company Overview 9
Eramet: Overview and Key Facts 9
Eramet: Overview 9
Eramet: Key Facts 9
Eramet: Key Employees 11
Eramet: Key Employee Biographies 13
Eramet: Major Products and Services 14
Eramet: Company History 15
Eramet: Management Statement 19
Eramet: Locations and Subsidiaries 21
Eramet: Key Competitors 23
Eramet: Company Analysis 24
Eramet: Business Description 24
Eramet: SWOT Analysis 26
Eramet: SWOT Overview 26
Eramet: Strengths 26
Eramet: Weaknesses 27
Eramet: Opportunities 27
Eramet: Threats 28
Eramet: Corporate Financial Deals Activity 30
Eramet: Financial Deals Overview 30
Eramet: Targets and Partners 31
Eramet: Top Deals 2014 – 2018YTD* 32
Eramet: Mergers and Acquisitions 33
Eramet: Capital Raising 34
Eramet: Divestments 35
Eramet: Recent Developments 36
Eramet: News and Events Summary 36
Eramet: Business Expansion 38
Eramet: Contracts 38
Eramet: Corporate Governance 39
Eramet: Financial Performance 39
Eramet: Strategy and Operations 40
Appendix 42
Contact Us 42
Methodology 42
About MarketLine 43

List of Tables
Table 1: Eramet: Key Facts
Table 2: Eramet: Key Employees
Table 3: Eramet: Company History
Table 4: Eramet: Locations and Subsidiaries
Table 5: Eramet: Key Competitors
Table 6: Eramet: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Eramet: Targets and Partners
Table 8: Eramet: Top Deals 2014 - 2018YTD*
Table 9: Eramet: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Eramet: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Eramet: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: Eramet: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: Eramet: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: Eramet: Divestments by Geography (2014 - YTD*2018)
Table 15: Eramet: News and Events Summary
Table 16: Eramet: Business Expansion
Table 17: Eramet: Contracts
Table 18: Eramet: Corporate Governance
Table 19: Eramet: Financial Performance
Table 20: Eramet: Strategy and Operations

List of Figures
Figure 1: Eramet: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Eramet: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: Eramet: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: Eramet: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 5: Eramet: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 6: Eramet: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 7: Eramet: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Eramet:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Andeavor (ANDV):企業の財務・戦略的SWOT分析
    Andeavor (ANDV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Pharmaceutical Product Development LLC:企業の戦略的SWOT分析
    Pharmaceutical Product Development LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • RPG Cables Limited:企業の戦略・SWOT・財務情報
    RPG Cables Limited - Strategy, SWOT and Corporate Finance Report Summary RPG Cables Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Starpharma Holdings Ltd (SPL):企業の財務・戦略的SWOT分析
    Starpharma Holdings Ltd (SPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Inchcape plc:企業の戦略・SWOT・財務分析
    Inchcape plc - Strategy, SWOT and Corporate Finance Report Summary Inchcape plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kohinoor Energy Limited (KOHE):企業の財務・戦略的SWOT分析
    Kohinoor Energy Limited (KOHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Borealis AG:企業の戦略的SWOT分析
    Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Esperite NV (ESP):企業の財務・戦略的SWOT分析
    Esperite NV (ESP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Acasti Pharma Inc (APO):企業の財務・戦略的SWOT分析
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in bl …
  • Sushico:企業の戦略・SWOT・財務分析
    Sushico - Strategy, SWOT and Corporate Finance Report Summary Sushico - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Cellmid Ltd (CDY):企業の財務・戦略的SWOT分析
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • Triskalia SCA:企業の戦略・SWOT・財務情報
    Triskalia SCA - Strategy, SWOT and Corporate Finance Report Summary Triskalia SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Newfoundland and Labrador Hydro:企業の戦略的SWOT分析
    Newfoundland and Labrador Hydro - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Abdullah Al-Othaim Markets Co.:企業の戦略・SWOT・財務情報
    Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report Summary Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AnaMar AB-医療機器分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • Talwalkars Better Value Fitness Ltd (TALWALKARS):企業の財務・戦略的SWOT分析
    Talwalkars Better Value Fitness Ltd (TALWALKARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • L’Oreal USA, Inc.:企業の戦略的SWOT分析
    L'Oreal USA, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • CTD Holdings Inc (CTDH):製薬・医療:M&Aディール及び事業提携情報
    Summary CTD Holdings Inc (CTDH), formerly Cyclodextrin Technologies Development Inc is a biotechnology company that develops, manufactures and distributes cyclodextrins products. The company’s products include aquaplex, trappsol and trappsol cyclo. It provides trappsol cyclo, which is a hydroxypropy …
  • Forendo Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Forendo Pharma Ltd (Forendo Pharma) is a drug development company that concentrates on tissue specific regulation of sex hormone effects. The company’s product pipeline include fispemifene, which is in clinical phase II development and intended for the treatment of lower urinary tract sympto …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆